Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...
Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...
US FDA accepts GSK’s submission for the use of Nucala to treat patients with chronic obstructive pulmonary disease: London, UK Wednesday, December 11, 2024, 10:00 Hrs [IST] GSK ...
Asthma and chronic obstructive pulmonary disease (COPD) are significant health challenges, with asthma affecting around ...